Topical Androgen Receptor Inhibitors Market - Top Companies and Manufacturers

Companies Dominating the Topical Androgen Receptor Inhibitors Market

Cosmo Pharmaceuticals
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Suzhou Kintor Pharmaceuticals Inc
Sun Pharmaceutical Industries Limited
Aranda Pharma Ltd
Selleck Chemicals

Browse Key Market Insights with Data Illustration:

Topical Androgen Receptor Inhibitors Market Size & Share, Global Forecast Report 2036

In the News

Aug 2020- The U.S. FDA has approved the first-in-class androgen receptor inhibitor, carotene cream 1% (Winlevi, Cassiopea), for the treatment of acne vulgaris in individuals 12 years of age and older.
Apr 2021- The National Medical Products Administration has given the green light for Kintor Pharmaceutical, a clinical-stage biotechnology company developing novel small molecule and biological therapeutics, to start GT20029 (gel/tincture) clinical trials for the treatment of androgenetic alopecia and acne.
Nov 2023- The supplemental new drug application for XTANDI® has been approved by the U.S. Food and Drug Administration (FDA), as announced by Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. With this approval, XTANDI turns out the first and only androgen receptor signaling inhibitor authorized by the FDA for the management of patients with biochemically driven recurrence of nonmetastatic castration-sensitive prostate cancer (nmCSPC) who are at high risk of developing metastatic disease.

Frequently Asked Questions (FAQ)

A rising aging population, growing healthcare spending and rising acceptance of cosmetic procedures are the major factors driving the growth of the topical androgen receptor inhibitors market.

The market size of topical androgen receptor inhibitors is anticipated to attain a CAGR of 14% over the forecast period, i.e., 2024 - 2036.

The major players in the market are Cosmo Pharmaceuticals, Suzhou Kintor Pharmaceuticals Inc., Sun Pharmaceutical Industries Limited, Aranda Pharma Ltd, Selleck Chemicals, Astellas Pharma, Takeda Pharmaceutical, and Daiichi Sankyo.

The Androgenetic Alopecia segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.

Topical Androgen Receptor Inhibitors Market - Top Companies and Manufacturers

Companies Dominating the Topical Androgen Receptor Inhibitors Market

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the topical androgen receptor inhibitors market?

What would be the CAGR of the topical androgen receptor inhibitors market over the forecast period?

Who are the major players dominating the topical androgen receptor inhibitors market?

Which segment captures the largest market size in the indication segment in the topical androgen receptor inhibitors market?

Which region will provide more business opportunities for the growth of the topical androgen receptor inhibitors market in the future?